Biosyent Inc (TSE:RX)
TSXV:RX
Canadian Market

Biosyent (RX) Financial Statements

40 Followers

Biosyent Financial Overview

Biosyent's market cap is currently ―. The company's EPS TTM is C$0.596; its P/E ratio is 16.76; and it has a dividend yield of 1.70%. Biosyent is scheduled to report earnings on August 20, 2024, and the estimated EPS forecast is C$0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total RevenueC$ 8.27MC$ 8.87MC$ 7.96MC$ 6.48MC$ 7.46M
Gross ProfitC$ 6.70MC$ 7.06MC$ 6.50MC$ 5.33MC$ 6.19M
EBITC$ 1.87MC$ 3.08MC$ 2.04MC$ 1.62MC$ 1.67M
EBITDAC$ 1.99MC$ 3.19MC$ 2.15MC$ 1.73MC$ 1.83M
Net Income Common StockholdersC$ 1.45MC$ 2.35MC$ 1.48MC$ 1.18MC$ 1.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 26.19MC$ 29.29MC$ 27.92MC$ 26.25MC$ 28.70M
Total AssetsC$ 41.53MC$ 41.40MC$ 39.51MC$ 38.75MC$ 40.49M
Total DebtC$ 1.22MC$ 1.27MC$ 1.31MC$ 1.35MC$ 1.40M
Net DebtC$ -24.97MC$ -28.02MC$ -26.61MC$ -24.90MC$ -27.30M
Total LiabilitiesC$ 6.77MC$ 6.85MC$ 6.44MC$ 5.33MC$ 7.12M
Stockholders EquityC$ 34.76MC$ 34.55MC$ 33.07MC$ 33.42MC$ 33.36M
Cash Flow-
Free Cash FlowC$ 622.65KC$ 2.39MC$ 3.06MC$ -1.19MC$ 1.87M
Operating Cash FlowC$ 674.99KC$ 2.41MC$ 3.07MC$ -1.10MC$ 2.16M
Investing Cash FlowC$ -916.50KC$ -976.08KC$ 1.83MC$ 949.05KC$ -1.48M
Financing Cash FlowC$ -1.29MC$ -1.14MC$ -2.03MC$ -1.33MC$ -1.01M
Currency in CAD

Biosyent Earnings and Revenue History

Biosyent Debt to Assets

Biosyent Cash Flow

Biosyent Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis